Efficacy of Erenumab in Chronic Cluster Headache

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Cluster HeadacheTrigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryBrain Disease
Interventions
BIOLOGICAL

Erenumab

Pre-filled syringe; s.c. injection

DRUG

Placebo

Pre-filled syring; s.c. injection

Trial Locations (11)

10117

Charité Universitätsmedizin Berlin, Berlin

17475

Universitätsmedizin Greifswald, Greifswald

18147

Universitätsklinikum Rostock, Rostock

24149

Schmerzklinik Kiel - Migräne- und Kopfschmerzzentrum, Kiel

34131

Vitos - Orthopädische Klinik gGmbH, Kassel

45133

Praxis für Neurologie, Nervenheilkunde, Psychosomatik, Essen

45147

Universitätsklinikum Essen, Essen

65929

Kopfschmerzzentrum Frankfurt, Frankfurt am Main

81377

LMU Klinikum München, München

01307

Universitätsklinik Dresden, Dresden

06120

Universitätsklinikum Halle, Halle

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT04970355 - Efficacy of Erenumab in Chronic Cluster Headache | Biotech Hunter | Biotech Hunter